A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A

Journal of the Neurological Sciences

Volumn 358, Issue 1-2, 2015, Pages 153-157

  Lv, He ^a   Wang, Lu ^a   Zhang, Wei ^a   Wang, Zhaoxia ^a   Zuo, Yuehuan ^a   Liu, Jing ^a   Yuan, Yun ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Axonal neuropathy; Charcot Maria Tooth; Early onset; Hereditary neuropathy; Mitofusin 2; Pathology

Indexed keywords

MITOFUSIN 2; GUANOSINE TRIPHOSPHATASE; MFN2 PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CHILD; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; ELECTRON MICROSCOPY; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; HAN CHINESE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIAN NERVE; MIDDLE AGED; MOTOR NERVE CONDUCTION; NERVE BIOPSY; NERVE CONDUCTION VELOCITY; NONMYELINATED NERVE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURAL NERVE; YOUNG ADULT; GENETICS; GENOTYPE; MUTATION; NERVE CONDUCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CHARCOT-MARIE-TOOTH DISEASE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENOTYPE; GTP PHOSPHOHYDROLASES; HUMANS; MALE; MEDIAN NERVE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MUTATION; NEURAL CONDUCTION; PHENOTYPE; SURAL NERVE; YOUNG ADULT;

EID: 84956839958     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2015.08.1528     Document Type: Article

References (22)

1. S. Züchner, I.V. Mersiyanova, M. Muglia, N. Bissar-Tadmouri, J. Rochelle, E.L. Dadali, M. Zappia, E. Nelis, A. Patitucci, J. Senderek, Y. Parman, O. Evgrafov, P.D. Jonghe, Y. Takahashi, S. Tsuji, M.A. Pericak-Vance, A. Quattrone, E. Battaloglu, A.V. Polyakov, V. Timmerman, J.M. Schröder, J.M. Vance, Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A, Nat. Genet. 36 (5) (2004) 449-451.
2. G. Montenegro, A. Peguero, N. Carlson, F. Speziani, J. Price, S.W. Taylor, M. Melanson, J.M. Vance, S. Züchner, Mutation screening of mitofusin 2 in Charcot-Marie-Tooth disease type 2, J. Neurol. 258 (7) (2011) 1234-1239.
3. S.M. Feely, M. Laura, C.E. Siskind, S. Sottile, M. Davis, V.S. Gibbons, et al., MFN2 mutations cause severe phenotypes in most patients with CMT2A, Neurology 76 (20) (2011) 1690-1696.
4. R.X. Zhang, M. Fu, X.H. Zi, X.B. Li, F.F. Zhang, K. Xia, Q. Pan, Z.M. Hu, B.S. Tang, Mutation analysis of MFN2 gene in Chinese patients with Charcot-Marie-Tooth disease, Natl. Med. J. China 89 (47) (2009) 3324-3327.
5. Y.W. Wang, W.T. Han, M. Jiang, C.X. Lu, X.F. Li, X. Zhang, J.X. Li, A novel mutation of the MFN2 gene in a Chinese family with Charcot-Marie-Tooth disease, Genet. Mol. Res. 11 (2) (2012) 1454-1459.
6. H. Lv, L. Wang, W. Li, X. Qiao, Y. Li, Z. Wang, Y. Yuan, Mitofusin 2 gene mutation causing early-onset CMT2A with different progressive courses, Clin. Neuropathol. 32 (1) (2013) 16-23.
7. K.P. Lin, B.W. Soong, C.C. Yang, L.W. Huang, M.H. Chang, I.H. Lee, A. Antonellis, Y.C. Lee, The mutational spectrum in a cohort of Charcot-Marie-Tooth disease type 2 among the Han Chinese in Taiwan, PLoS One 6 (12) (2011), e29393.
8. F. Bombelli, T. Stojkovic, O. Dubourg, A. Echaniz-Laguna, S. Tardieu, K. Larcher, P. Amati-Bonneau, P. Latour, O. Vignal, C. Cazeneuve, A. Brice, E. Leguern, Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features, JAMA Neurol. 71 (8) (2014) 1036-1042.
9. K.W. Chung, S.B. Kim, K.D. Park, K.G. Choi, J.H. Lee, H.W. Eun, J.S. Suh, J.H. Hwang, W.K. Kim, B.C. Seo, S.H. Kim, I.H. Son, S.M. Kim, I.N. Sunwoo, Choi BO Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations, Brain 29 (Pt 8) (2006) 2103-2118.
10. J. Calvo, B. Funalot, R.A. Ouvrier, L. Lazaro, A. Toutain, P. De Mas, P. Bouche, B. Gilbert-Dussardier, M.C. Arne-Bes, J.P. Carrière, H. Journel, M.C. Minot-Myhie, C. Guillou, K. Ghorab, L. Magy, F. Sturtz, J.M. Vallat, C. Magdelaine, Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations, Arch. Neurol. 66 (2009) 1511-1516.
11. S. Züchner, P. De Jonghe, A. Jordanova, K.G. Claeys, V. Guergueltcheva, S. Cherninkova, S.R. Hamilton, G. Van Stavern, K.M. Krajewski, J. Stajich, I. Tournev, K. Verhoeven, C.T. Langerhorst, M. de Visser, F. Baas, T. Bird, V. Timmerman, M. Shy, J.M. Vance, Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2, Ann. Neurol. 59 (2006) 276-281.
12. I. Banchs, C. Casasnovas, J. Montero, J.A. Martínez-Matos, V. Volpini, Two Spanish families with Charcot-Marie-Tooth type 2A: clinical, electrophysiological and molecular findings, Neuromuscul. Disord. 18 (12) (2008) 974-978.
13. R. Ouvrier, S. Grew, Mechanisms of disease and clinical features of mutations of the gene for mitofusin 2: an important cause of hereditary peripheral neuropathy with striking clinical variability in children and adults, Dev. Med. Child Neurol. 52 (4) (2010) 328-330.
14. J.M. Vallat, R.A. Ouvrier, J.D. Pollard, C. Magdelaine, D. Zhu, G.A. Nicholson, S. Grew, M.M. Ryan, B. Funalot, Histopathological findings in hereditary motor and sensory neuropathy of axonal type with onset in early childhood associated with mitofusin 2 mutations, J. Neuropathol. Exp. Neurol. 67 (11) (2008) 1097-1102.
15. K. Verhoeven, K.G. Claeys, S. Züchner, J.M. Schröder, J. Weis, C. Ceuterick, A. Jordanova, E. Nelis, E. De Vriendt, M. Van Hul, P. Seeman, R. Mazanec, G.M. Saifi, K. Szigeti, P. Mancias, I.J. Butler, A. Kochanski, B. Ryniewicz, J. De Bleecker, P. Van den Bergh, C. Verellen, R. Van Coster, N. Goemans, M. Auer-Grumbach, W. Robberecht, V. Milic Rasic, Y. Nevo, I. Tournev, V. Guergueltcheva, F. Roelens, P. Vieregge, P. Vinci, M.T. Moreno, H.J. Christen, M.E. Shy, J.R. Lupski, J.M. Vance, P. De Jonghe, Timmerman VMFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2, Brain 129 (8) (2006) 2093-2102.
16. G. Sole, X. Ferrer, C. Vital, M.L. Martin-Negrier, A. Vital, P. Latour, Ultrastructural mitochondrial modifications characteristic of mitofusin 2 mutations (CMT2A), J. Peripher. Nerv. Syst. 14 (3) (2009) 206-207.
17. K. Brockmann, S. Dreha-Kulaczewski, P. Dechent, C. Bönnemann, G. Helms, M. Kyllerman, W. Brück, J. Frahm, K. Huehne, J. Gärtner, B. Rautenstrauss, Cerebral involvement in axonal Charcot-Marie-Tooth neuropathy caused by mitofusin2 mutations, J. Neurol. 255 (7) (2008) 1049-1058.
18. R. Del Bo, M. Moggio, M. Rango, S. Bonato, M.G. D'Angelo, S. Ghezzi, G. Airoldi, M.T. Bassi, M. Guglieri, L. Napoli, C. Lamperti, S. Corti, A. Federico, N. Bresolin, G.P. Comi, Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction, Neurology 71 (24) (2008) 1959-1966.
19. A.B. Genari, V.H. Borghetti, S.P. Gouvêa, K.C. Bueno, P.L. dos Santos, A.C. dos Santos, A.A. Barreira, C.M. Lourenço, W. Marques Jr., Characterizing the phenotypic manifestations of MFN2 R104W mutation in Charcot-Marie-Tooth type 2, Neuromuscul. Disord. 21 (6) (2011) 428-432.
20. C. Casasnovas, I. Banchs, J. Cassereau, N. Gueguen, A. Chevrollier, J.A. Martínez-Matos, D. Bonneau, V. Volpini, Phenotypic spectrum of MFN2 mutations in the Spanish population, J. Med. Genet. 47 (4) (2010) 249-256.
21. C. Neusch, J. Senderek, T. Eggermann, E. Elolff, M. Bähr, C. Schneider-Gold, Mitofusin 2 gene mutation (R94Q) causing severe early-onset axonal polyneuropathy (CMT2A), Eur. J. Neurol. 14 (5) (2007) 575-577.
22. Choi BO, Nakhro K, Park HJ, Hyun YS, Lee JH, Kanwal S, Jung SC, Chung KW (2014). A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients. Clin Genet 2015, 87 (6):594-598.